HBM Healthcare Investments (Cayman) Ltd., 10% Owner at Nabriva Therapeutics plc (NBRV), sold 69,787 shares at $8.54 ($598K) on 2017-09-13, disclosed to the SEC on 2017-09-14.
Open-market sale of $598k NBRV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.63 | 10,458 | $90K | 15.1% |
| 2 | $8.63 | 10,458 | $90K | 15.1% |
| 3 | $8.54 | 22,721 | $194K | 32.5% |
| 4 | $8.54 | 22,721 | $194K | 32.5% |
| 5 | $8.52 | 3,429 | $29K | 4.9% |
| Total | $8.57 avg | 69,787 |
| $598K |
| 100% |
| Filing → |
| NBRV | SELL | 2017-09-05 | $6K | — | Filing → |
| NBRV | SELL | 2017-08-09 | $208K | — | Filing → |
| NBRV | SELL | 2017-08-01 | $138K | — | Filing → |